CYCLOSPORINE

CYCLOSPORINE was reported 112834 times

These side effects are most commonly reported by patients taking CYCLOSPORINE:

# Side effect Count
0 DRUG INEFFECTIVE 13231
1 OFF LABEL USE 10019
2 EYE IRRITATION 8140
3 PRODUCT USE IN UNAPPROVED INDICATION 4398
4 PYREXIA 4229
5 EYE PAIN 4023
6 NAUSEA 3828
7 HEADACHE 3802
8 DIARRHOEA 3784
9 FATIGUE 3585
10 PNEUMONIA 3455
11 CONDITION AGGRAVATED 3324
12 PAIN 3290
13 VISION BLURRED 2947
14 RASH 2754
15 PRURITUS 2733
16 DYSPNOEA 2684
17 DEATH 2521
18 OCULAR HYPERAEMIA 2480
19 ARTHRALGIA 2474
20 HYPERTENSION 2471
21 VOMITING 2388
22 CYTOMEGALOVIRUS INFECTION 2328
23 DRY EYE 2243
24 SEPSIS 2197
25 RENAL IMPAIRMENT 2185
26 INFECTION 2112
27 BLOOD CREATININE INCREASED 2052
28 MALAISE 2008
29 TREATMENT FAILURE 1924
30 RENAL FAILURE 1914
31 DRUG INTERACTION 1874
32 DRUG INTOLERANCE 1867
33 ANAEMIA 1866
34 PAIN IN EXTREMITY 1848
35 ACUTE KIDNEY INJURY 1844
36 DIZZINESS 1818
37 ASTHENIA 1790
38 PSORIASIS 1776
39 GRAFT VERSUS HOST DISEASE 1744
40 ERYTHEMA 1735
41 PRODUCT USE ISSUE 1715
42 COUGH 1655
43 HYPERSENSITIVITY 1649
44 URTICARIA 1636
45 LACRIMATION INCREASED 1590
46 THROMBOCYTOPENIA 1539
47 ABDOMINAL PAIN 1529
48 WEIGHT DECREASED 1517
49 DRUG HYPERSENSITIVITY 1508
50 RHEUMATOID ARTHRITIS 1470
51 FALL 1464
52 ALOPECIA 1438
53 URINARY TRACT INFECTION 1425
54 INCORRECT DOSE ADMINISTERED 1397
55 NEUTROPENIA 1368
56 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1360
57 PANCYTOPENIA 1334
58 EYE PRURITUS 1315
59 TRANSPLANT REJECTION 1311
60 INSOMNIA 1309
61 ACUTE GRAFT VERSUS HOST DISEASE 1306
62 PLATELET COUNT DECREASED 1292
63 RESPIRATORY FAILURE 1262
64 COVID-19 1227
65 CHRONIC GRAFT VERSUS HOST DISEASE 1214
66 DISEASE PROGRESSION 1197
67 PRODUCT DOSE OMISSION ISSUE 1196
68 FEBRILE NEUTROPENIA 1174
69 BLOOD PRESSURE INCREASED 1167
70 PERIPHERAL SWELLING 1160
71 VISUAL IMPAIRMENT 1132
72 JOINT SWELLING 1131
73 BACK PAIN 1124
74 SEPTIC SHOCK 1118
75 CYTOMEGALOVIRUS INFECTION REACTIVATION 1116
76 HAEMOGLOBIN DECREASED 1104
77 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1102
78 FOREIGN BODY SENSATION IN EYES 1088
79 ALANINE AMINOTRANSFERASE INCREASED 1080
80 NASOPHARYNGITIS 1079
81 THERAPY NON-RESPONDER 1078
82 THROMBOTIC MICROANGIOPATHY 1070
83 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1064
84 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1062
85 NEPHROPATHY TOXIC 1060
86 WEIGHT INCREASED 1057
87 EPSTEIN-BARR VIRUS INFECTION 1047
88 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1040
89 C-REACTIVE PROTEIN INCREASED 1027
90 MYALGIA 991
91 MUCOSAL INFLAMMATION 988
92 DECREASED APPETITE 986
93 LEUKOPENIA 977
94 PRODUCT CONTAINER ISSUE 962
95 HERPES ZOSTER 956
96 THERAPEUTIC RESPONSE DECREASED 956
97 CATARACT 947
98 MULTIPLE ORGAN DYSFUNCTION SYNDROME 944
99 ARTHRITIS 940
100 ANXIETY 932
101 PRODUCT STORAGE ERROR 932
102 FEELING ABNORMAL 927
103 ASPARTATE AMINOTRANSFERASE INCREASED 921
104 MUSCLE SPASMS 921
105 GAIT DISTURBANCE 907
106 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 894
107 ABDOMINAL DISCOMFORT 885
108 STOMATITIS 877
109 HYPOTENSION 876
110 SINUSITIS 873
111 INFLAMMATION 872
112 DISEASE RECURRENCE 869
113 TREMOR 850
114 OEDEMA PERIPHERAL 849
115 BK VIRUS INFECTION 848
116 HEPATIC FUNCTION ABNORMAL 842
117 HEPATIC ENZYME INCREASED 831
118 PSORIATIC ARTHROPATHY 822
119 INFLUENZA 821
120 EYE SWELLING 819
121 KIDNEY TRANSPLANT REJECTION 818
122 CONSTIPATION 815
123 GENERAL PHYSICAL HEALTH DETERIORATION 808
124 RENAL FAILURE ACUTE 807
125 CONTRAINDICATED PRODUCT ADMINISTERED 806
126 ABDOMINAL PAIN UPPER 792
127 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 790
128 ACCIDENTAL EXPOSURE TO PRODUCT 782
129 TOXICITY TO VARIOUS AGENTS 781
130 WHITE BLOOD CELL COUNT DECREASED 777
131 CHEST PAIN 775
132 DIABETES MELLITUS 775
133 DEPRESSION 772
134 EYE DISCHARGE 768
135 THERAPEUTIC PRODUCT EFFECT DECREASED 767
136 MUSCULOSKELETAL STIFFNESS 764
137 MUSCULAR WEAKNESS 761
138 INFUSION RELATED REACTION 745
139 MULTIPLE USE OF SINGLE-USE PRODUCT 741
140 CHILLS 735
141 CONFUSIONAL STATE 729
142 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 728
143 DRUG DOSE OMISSION 719
144 PLEURAL EFFUSION 716
145 PRODUCT DOSE OMISSION 713
146 GASTROINTESTINAL DISORDER 708
147 CYTOMEGALOVIRUS VIRAEMIA 690
148 RHABDOMYOLYSIS 685
149 INTERSTITIAL LUNG DISEASE 682
150 PHOTOPHOBIA 675
151 ARTHROPATHY 674
152 FUNGAL INFECTION 674
153 HYPOAESTHESIA 673
154 SYNOVITIS 673
155 STAPHYLOCOCCAL INFECTION 672
156 BLOOD BILIRUBIN INCREASED 651
157 DEHYDRATION 647
158 BACTERIAL INFECTION 646
159 OCULAR DISCOMFORT 643
160 PARAESTHESIA 641
161 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 638
162 OEDEMA 638
163 INTENTIONAL PRODUCT USE ISSUE 636
164 SOMNOLENCE 634
165 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 630
166 APLASTIC ANAEMIA 620
167 ACNE 614
168 DRUG ERUPTION 614
169 BURNING SENSATION 613
170 OROPHARYNGEAL PAIN 613
171 EPISTAXIS 608
172 BASAL CELL CARCINOMA 606
173 MULTI-ORGAN FAILURE 604
174 BRONCHOPULMONARY ASPERGILLOSIS 602
175 CELLULITIS 602
176 CYSTITIS HAEMORRHAGIC 598
177 SWELLING 595
178 GRAFT VERSUS HOST DISEASE IN SKIN 591
179 TRANSPLANT DYSFUNCTION 591
180 DRUG RESISTANCE 590
181 DYSPHAGIA 588
182 GASTROINTESTINAL HAEMORRHAGE 588
183 RENAL DISORDER 588
184 BRONCHITIS 586
185 CHRONIC KIDNEY DISEASE 573
186 CARDIAC FAILURE 567
187 ANGIOEDEMA 564
188 INJECTION SITE PAIN 564
189 LUNG DISORDER 564
190 MIGRAINE 564
191 RASH PRURITIC 562
192 CONTUSION 558
193 LIVER FUNCTION TEST ABNORMAL 558
194 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 557
195 SKIN LESION 550
196 ATRIAL FIBRILLATION 549
197 SKIN ULCER 542
198 ADENOVIRUS INFECTION 535
199 ANAPHYLACTIC REACTION 535
200 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 526
201 HEART RATE INCREASED 526
202 RHINORRHOEA 526
203 SKIN EXFOLIATION 525
204 EYE DISORDER 523
205 PROTEINURIA 523
206 DRY SKIN 518
207 NEUROPATHY PERIPHERAL 515
208 PSEUDOMONAS INFECTION 512
209 LOSS OF CONSCIOUSNESS 511
210 MOBILITY DECREASED 504
211 THERAPY CESSATION 503
212 MYOCARDIAL INFARCTION 501
213 ILLNESS 498
214 LYMPHADENOPATHY 498
215 RED BLOOD CELL SEDIMENTATION RATE INCREASED 487
216 DRY MOUTH 484
217 LIVER DISORDER 483
218 VIRAL INFECTION 477
219 OVARIAN CYST 476
220 HAEMORRHAGE 475
221 MATERNAL EXPOSURE DURING PREGNANCY 474
222 CONVULSION 473
223 BONE MARROW FAILURE 472
224 BLOOD LACTATE DEHYDROGENASE INCREASED 469
225 ABDOMINAL DISTENSION 462
226 SEIZURE 462
227 CEREBROVASCULAR ACCIDENT 461
228 OSTEOPOROSIS 460
229 TACHYCARDIA 455
230 OVERDOSE 454
231 MEMORY IMPAIRMENT 447
232 BACTERAEMIA 446
233 VENOOCCLUSIVE LIVER DISEASE 446
234 ACUTE RESPIRATORY DISTRESS SYNDROME 444
235 VISUAL ACUITY REDUCED 443
236 NECK PAIN 439
237 HEPATIC FAILURE 437
238 SWELLING FACE 432
239 ASTHMA 431
240 PNEUMOCYSTIS JIROVECII PNEUMONIA 430
241 OSTEOARTHRITIS 428
242 EXPIRED PRODUCT ADMINISTERED 427
243 UPPER RESPIRATORY TRACT INFECTION 427
244 HAEMATURIA 426
245 THERAPY PARTIAL RESPONDER 426
246 STRESS 421
247 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 420
248 PULMONARY EMBOLISM 419
249 DRUG LEVEL INCREASED 414
250 HYPERCALCAEMIA 414
251 ASPERGILLUS INFECTION 413
252 BLOOD GLUCOSE INCREASED 413
253 DYSPEPSIA 405
254 BLOOD CHOLESTEROL INCREASED 403
255 ADVERSE EVENT 401
256 NEUROTOXICITY 399
257 ADVERSE DRUG REACTION 396
258 ULCER 396
259 CHEST DISCOMFORT 392
260 HYPOGAMMAGLOBULINAEMIA 389
261 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 387
262 SLEEP DISORDER 387
263 BLOOD UREA INCREASED 385
264 RESPIRATORY DISTRESS 384
265 ASCITES 381
266 DISCOMFORT 380
267 HYPOXIA 380
268 BLOOD ALKALINE PHOSPHATASE INCREASED 379
269 HYPERHIDROSIS 379
270 TRANSAMINASES INCREASED 377
271 HYPERKALAEMIA 376
272 HEPATOTOXICITY 374
273 BLISTER 373
274 GASTROOESOPHAGEAL REFLUX DISEASE 373
275 HEPATITIS 373
276 PALPITATIONS 372
277 C-REACTIVE PROTEIN ABNORMAL 371
278 SKIN DISORDER 370
279 NEPHROTIC SYNDROME 368
280 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 367
281 PRODUCT QUALITY ISSUE 363
282 CARDIAC ARREST 361
283 MUSCULOSKELETAL PAIN 359
284 BLOOD PRESSURE DECREASED 358
285 DYSGEUSIA 358
286 GAMMA-GLUTAMYLTRANSFERASE INCREASED 355
287 HOSPITALISATION 355
288 NASAL CONGESTION 355
289 BALANCE DISORDER 354
290 ENCEPHALOPATHY 346
291 LYMPHOPENIA 342
292 PERICARDIAL EFFUSION 342
293 SURGERY 341
294 CANDIDA INFECTION 340
295 CLOSTRIDIUM DIFFICILE COLITIS 338
296 COMPLICATIONS OF TRANSPLANTED KIDNEY 338
297 SKIN NECROSIS 338
298 PRODUCTIVE COUGH 337
299 INSTILLATION SITE PAIN 336
300 ECZEMA 335
301 NEOPLASM MALIGNANT 335
302 OXYGEN SATURATION DECREASED 334
303 ENTEROCOCCAL INFECTION 332
304 THROMBOSIS 332
305 CHOLESTASIS 331
306 SYSTEMIC LUPUS ERYTHEMATOSUS 325
307 DISSEMINATED INTRAVASCULAR COAGULATION 324
308 DEEP VEIN THROMBOSIS 322
309 CYSTITIS 320
310 NO ADVERSE EVENT 320
311 WHITE BLOOD CELL COUNT INCREASED 319
312 INTENTIONAL PRODUCT MISUSE 318
313 PULMONARY OEDEMA 318
314 CEREBRAL HAEMORRHAGE 314
315 FOETAL EXPOSURE DURING PREGNANCY 313
316 HERPES SIMPLEX 311
317 MYELOSUPPRESSION 310
318 HYPONATRAEMIA 309
319 OSTEONECROSIS 309
320 PANNICULITIS 309
321 EYELID OEDEMA 308
322 HALLUCINATION 307
323 RENAL TUBULAR NECROSIS 306
324 SQUAMOUS CELL CARCINOMA 306
325 DYSURIA 305
326 TRANSPLANT FAILURE 305
327 COLITIS 303
328 BLINDNESS 301
329 BLOOD CREATINE PHOSPHOKINASE INCREASED 299
330 DEPRESSED LEVEL OF CONSCIOUSNESS 297
331 IMPAIRED HEALING 297
332 DYSPHONIA 296
333 SYNCOPE 296
334 GLAUCOMA 295
335 HAEMODIALYSIS 295
336 HOT FLUSH 295
337 ERYTHEMA OF EYELID 294
338 KLEBSIELLA INFECTION 294
339 ACUTE MYELOID LEUKAEMIA 293
340 DERMATITIS ATOPIC 293
341 JAUNDICE 292
342 PANCREATITIS 288
343 THERAPY INTERRUPTED 288
344 CARDIAC FAILURE CONGESTIVE 287
345 PULMONARY FIBROSIS 286
346 MOUTH ULCERATION 285
347 RESPIRATORY TRACT INFECTION 285
348 DRUG-INDUCED LIVER INJURY 283
349 PNEUMONIA CYTOMEGALOVIRAL 283
350 AGRANULOCYTOSIS 281
351 BLOOD PARATHYROID HORMONE DECREASED 281
352 SKIN PLAQUE 281
353 BLOOD PRESSURE SYSTOLIC INCREASED 280
354 CARDIAC DISORDER 280
355 EYE INFECTION 279
356 PRODUCT USE COMPLAINT 278
357 ESCHERICHIA INFECTION 276
358 RHEUMATOID NODULE 276
359 SKIN DISCOLOURATION 275
360 EMOTIONAL DISTRESS 274
361 ILL-DEFINED DISORDER 272
362 EYE INFLAMMATION 271
363 INJURY 270
364 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 269
365 TUBULOINTERSTITIAL NEPHRITIS 269
366 NEUTROPHIL COUNT DECREASED 268
367 ACUTE RESPIRATORY FAILURE 267
368 HAEMATOCHEZIA 266
369 METABOLIC ACIDOSIS 266
370 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 265
371 ABNORMAL SENSATION IN EYE 264
372 PNEUMONIA BACTERIAL 264
373 HAEMOLYSIS 262
374 PREMATURE BABY 262
375 VENOOCCLUSIVE DISEASE 262
376 RASH ERYTHEMATOUS 261
377 THROAT IRRITATION 261
378 BONE PAIN 260
379 FIBROMYALGIA 260
380 GENERALISED OEDEMA 259
381 LUNG INFILTRATION 257
382 MYELODYSPLASTIC SYNDROME 256
383 CYTOPENIA 254
384 LIVER TRANSPLANT REJECTION 253
385 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 253
386 INFLUENZA LIKE ILLNESS 250
387 AMNESIA 249
388 CLOSTRIDIUM DIFFICILE INFECTION 249
389 RESPIRATORY DISORDER 249
390 COLITIS ULCERATIVE 248
391 DYSPNOEA EXERTIONAL 248
392 HUMAN HERPESVIRUS 6 INFECTION 248
393 HYPERGLYCAEMIA 248
394 LOWER RESPIRATORY TRACT INFECTION 248
395 ORAL PAIN 247
396 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 247
397 UNEVALUABLE EVENT 247
398 VERTIGO 247
399 DERMATITIS 246
400 FLUID RETENTION 246
401 MALIGNANT NEOPLASM PROGRESSION 246
402 PRODUCT PACKAGING QUANTITY ISSUE 246
403 DIPLOPIA 244
404 HYPERBILIRUBINAEMIA 244
405 FEELING HOT 243
406 STAPHYLOCOCCAL SEPSIS 243
407 WOUND 243
408 SPLENOMEGALY 240
409 FLUSHING 237
410 GINGIVAL HYPERTROPHY 237
411 INCORRECT PRODUCT STORAGE 237
412 LYMPHOPROLIFERATIVE DISORDER 236
413 DEVICE RELATED INFECTION 235
414 GRANULOMA SKIN 235
415 HYPOKALAEMIA 235
416 RED BLOOD CELL COUNT DECREASED 235
417 HAEMATOCRIT DECREASED 234
418 MYOPATHY 234
419 WHEEZING 234
420 END STAGE RENAL DISEASE 233
421 INJECTION SITE ERYTHEMA 233
422 SJOGREN^S SYNDROME 233
423 ACUTE MYELOID LEUKAEMIA RECURRENT 232
424 HISTIOCYTOSIS HAEMATOPHAGIC 232
425 HYPOTHYROIDISM 232
426 MENTAL DISORDER 232
427 HEPATIC CIRRHOSIS 230
428 ORAL HERPES 230
429 ASPERGILLOSIS 229
430 BRAIN OEDEMA 229
431 EPSTEIN-BARR VIRAEMIA 229
432 PAIN OF SKIN 229
433 PYELONEPHRITIS 229
434 SPEECH DISORDER 229
435 TINNITUS 229
436 COMA 228
437 PNEUMONITIS 228
438 DIFFUSE LARGE B-CELL LYMPHOMA 227
439 STAPHYLOCOCCAL BACTERAEMIA 227
440 APLASIA PURE RED CELL 225
441 SERUM FERRITIN INCREASED 224
442 TENDONITIS 223
443 CEREBRAL INFARCTION 222
444 DRUG EXPOSURE DURING PREGNANCY 222
445 THERAPEUTIC RESPONSE UNEXPECTED 222
446 CONJUNCTIVITIS 221
447 TOXIC EPIDERMAL NECROLYSIS 221
448 SHOCK 218
449 LETHARGY 217
450 NERVOUS SYSTEM DISORDER 216
451 ASTHENOPIA 214
452 RENAL FAILURE CHRONIC 213
453 SKIN CANCER 213
454 RASH MACULO-PAPULAR 211
455 SWELLING OF EYELID 211
456 VIRAL HAEMORRHAGIC CYSTITIS 211
457 IMMUNOSUPPRESSION 210
458 INJECTION SITE BRUISING 209
459 CYTOMEGALOVIRUS COLITIS 207
460 DIVERTICULITIS 207
461 HEPATITIS C 207
462 LEUKOCYTOSIS 207
463 EXPOSURE DURING PREGNANCY 206
464 OSTEOMYELITIS 206
465 ARRHYTHMIA 205
466 CHOLELITHIASIS 204
467 GRAFT VERSUS HOST DISEASE IN LIVER 204
468 GAIT INABILITY 203
469 GASTRITIS 203
470 PERITONITIS 203
471 PRODUCT DROPPER ISSUE 202
472 SKIN BURNING SENSATION 202
473 SKIN INFECTION 202
474 COVID-19 PNEUMONIA 201
475 DYSARTHRIA 201
476 EYELID PAIN 201
477 COGNITIVE DISORDER 200
478 DRUG TOLERANCE DECREASED 200
479 HAEMOLYTIC ANAEMIA 199
480 PRODUCT ADMINISTRATION ERROR 199
481 SUICIDAL IDEATION 199
482 DISORIENTATION 198
483 OSTEOPENIA 198
484 FLATULENCE 197
485 LYMPHOMA 197
486 OBLITERATIVE BRONCHIOLITIS 197
487 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 197
488 CHRONIC SPONTANEOUS URTICARIA 196
489 ALTERED STATE OF CONSCIOUSNESS 195
490 HYPOALBUMINAEMIA 195
491 LIVER INJURY 195
492 AGITATION 194
493 HAEMORRHAGE INTRACRANIAL 194
494 PANCREATITIS ACUTE 194
495 PNEUMONIA FUNGAL 194
496 ANURIA 193
497 HEPATIC STEATOSIS 193
498 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 192
499 LIP SWELLING 192
500 REBOUND EFFECT 192
501 TREATMENT NONCOMPLIANCE 192
502 APHASIA 191
503 BACTERIAL SEPSIS 191
504 NEPHROLITHIASIS 190
505 SQUAMOUS CELL CARCINOMA OF SKIN 190
506 ABSCESS 189
507 GASTRIC DISORDER 189
508 JOINT INJURY 188
509 LIVER FUNCTION TEST INCREASED 188
510 INJECTION SITE REACTION 187
511 CUSHINGOID 186
512 DEAFNESS 186
513 DISTURBANCE IN ATTENTION 186
514 LUNG INFECTION 186
515 NERVOUSNESS 184
516 UVEITIS 184
517 GASTROENTERITIS 183
518 LIMB DISCOMFORT 183
519 HEART TRANSPLANT REJECTION 182
520 PLATELET COUNT INCREASED 182
521 PULMONARY HYPERTENSION 182
522 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 181
523 MALIGNANT MELANOMA 181
524 POST PROCEDURAL COMPLICATION 181
525 PYODERMA GANGRENOSUM 181
526 URINE OUTPUT DECREASED 181
527 BRADYCARDIA 180
528 TENDERNESS 180
529 TUBERCULOSIS 180
530 BLOOD PRESSURE FLUCTUATION 178
531 HAEMOPTYSIS 178
532 PHOTOSENSITIVITY REACTION 178
533 PRODUCT DELIVERY MECHANISM ISSUE 178
534 CROHN^S DISEASE 176
535 DRUG LEVEL DECREASED 176
536 COAGULOPATHY 175
537 DIALYSIS 175
538 PRODUCT PRESCRIBING ERROR 175
539 HYPERCHOLESTEROLAEMIA 174
540 INTRAOCULAR PRESSURE INCREASED 174
541 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 174
542 RHEUMATOID FACTOR POSITIVE 174
543 VIRAEMIA 174
544 PRODUCT PRESCRIBING ISSUE 173
545 DEPRESSED MOOD 172
546 PNEUMOTHORAX 172
547 PULMONARY HAEMORRHAGE 172
548 RASH MACULAR 172
549 TENOSYNOVITIS 172
550 LOCALISED INFECTION 171
551 MELAENA 171
552 PERICARDITIS 171
553 ENCEPHALITIS 170
554 TYPE 2 DIABETES MELLITUS 170
555 CYTOMEGALOVIRUS TEST POSITIVE 169
556 EAR INFECTION 169
557 EAR PAIN 169
558 LEUKOENCEPHALOPATHY 169
559 ORAL CANDIDIASIS 169
560 SNEEZING 169
561 BODY TEMPERATURE INCREASED 168
562 BREAST CANCER 168
563 IMPAIRED GASTRIC EMPTYING 168
564 INTESTINAL OBSTRUCTION 168
565 MUCORMYCOSIS 168
566 MUSCULOSKELETAL DISORDER 168
567 SCLERAL HYPERAEMIA 168
568 TONGUE DISORDER 168
569 CHRONIC ALLOGRAFT NEPHROPATHY 167
570 EMOTIONAL DISORDER 167
571 HAND DEFORMITY 167
572 MENTAL STATUS CHANGES 167
573 HAEMATOMA 166
574 INJECTION SITE SWELLING 166
575 NIGHT SWEATS 166
576 ENTHESOPATHY 165
577 OLIGURIA 165
578 PATHOGEN RESISTANCE 164
579 POLLAKIURIA 164
580 HEART RATE DECREASED 163
581 LOW BIRTH WEIGHT BABY 162
582 PNEUMONIA ASPIRATION 162
583 DRUG TOXICITY 161
584 GOUT 161
585 PNEUMONIA VIRAL 161
586 ALANINE AMINOTRANSFERASE ABNORMAL 160
587 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 160
588 CYTOMEGALOVIRUS CHORIORETINITIS 160
589 HYPERLIPIDAEMIA 160
590 HYPOACUSIS 160
591 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 159
592 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 159
593 INJECTION SITE HAEMORRHAGE 159
594 EPILEPSY 158
595 IMMUNE SYSTEM DISORDER 158
596 STEM CELL TRANSPLANT 158
597 SUPERFICIAL INJURY OF EYE 158
598 VASCULITIS 158
599 WRONG TECHNIQUE IN DRUG USAGE PROCESS 158
600 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 157
601 HEPATITIS B 157
602 NOCARDIOSIS 157
603 PULMONARY ALVEOLAR HAEMORRHAGE 157
604 GASTRIC ULCER 156
605 NEPHROPATHY 156
606 PNEUMOCYSTIS JIROVECI PNEUMONIA 156
607 KAPOSI^S SARCOMA 155
608 POLYOMAVIRUS VIRAEMIA 155
609 PSEUDOMONAL SEPSIS 155
610 VITREOUS FLOATERS 155
611 DEMYELINATION 154
612 EYELID IRRITATION 154
613 PAIN IN JAW 154
614 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 153
615 IMMUNODEFICIENCY 153
616 KIDNEY FIBROSIS 153
617 PNEUMATOSIS INTESTINALIS 153
618 PRESCRIBED UNDERDOSE 153
619 STILL^S DISEASE 153
620 UROSEPSIS 152
621 ANOREXIA 151
622 MEDICATION ERROR 151
623 DEVICE ISSUE 150
624 DRUG EFFECT DECREASED 150
625 HEMIPARESIS 150
626 UPPER LIMB FRACTURE 150
627 GLOSSODYNIA 149
628 HEPATOMEGALY 149
629 RECTAL HAEMORRHAGE 149
630 THROMBOTIC THROMBOCYTOPENIC PURPURA 149
631 SKIN IRRITATION 148
632 VARICELLA ZOSTER VIRUS INFECTION 147
633 BLOOD TRIGLYCERIDES INCREASED 146
634 CORONARY ARTERY DISEASE 146
635 LIMB INJURY 146
636 PUSTULAR PSORIASIS 146
637 SCIATICA 146
638 BRONCHIECTASIS 145
639 LABORATORY TEST ABNORMAL 145
640 SINUS DISORDER 145
641 ACUTE MYOCARDIAL INFARCTION 144
642 DELIRIUM 144
643 FOOT DEFORMITY 144
644 HYDRONEPHROSIS 144
645 NEURALGIA 144
646 PREMATURE DELIVERY 144
647 SWOLLEN TONGUE 144
648 EYELID PTOSIS 143
649 FEEDING DISORDER 143
650 GLOMERULAR FILTRATION RATE DECREASED 143
651 JOINT STIFFNESS 143
652 MYASTHENIA GRAVIS 143
653 IRRITABILITY 142
654 LYMPHOCYTE COUNT DECREASED 142
655 BLOOD POTASSIUM INCREASED 141
656 DRUG TOLERANCE 141
657 PRODUCT SUBSTITUTION ISSUE 141
658 QUALITY OF LIFE DECREASED 141
659 IMMUNE THROMBOCYTOPENIA 140
660 LYMPHOCELE 140
661 ROAD TRAFFIC ACCIDENT 140
662 STEVENS-JOHNSON SYNDROME 140
663 LUNG NEOPLASM MALIGNANT 139
664 RENAL INJURY 139
665 ACCIDENTAL OVERDOSE 138
666 HAEMOLYTIC URAEMIC SYNDROME 138
667 SKIN FISSURES 138
668 HELICOBACTER INFECTION 137
669 MADAROSIS 137
670 PULMONARY CONGESTION 137
671 ANKYLOSING SPONDYLITIS 136
672 GRAND MAL CONVULSION 136
673 HYPOGLYCAEMIA 136
674 JC VIRUS INFECTION 136
675 SCLERODERMA 136
676 ANGINA PECTORIS 135
677 CANDIDIASIS 135
678 CARDIO-RESPIRATORY ARREST 135
679 HERPES VIRUS INFECTION 135
680 INJECTION SITE PRURITUS 135
681 INTRACRANIAL PRESSURE INCREASED 135
682 UNDERDOSE 135
683 GRANULOMA 134
684 LEUKAEMIA RECURRENT 134
685 RASH PAPULAR 134
686 SLEEP APNOEA SYNDROME 134
687 SYSTEMIC CANDIDA 134
688 URINARY INCONTINENCE 134
689 MOVEMENT DISORDER 133
690 CONCOMITANT DISEASE AGGRAVATED 132
691 PULMONARY MASS 131
692 JOINT RANGE OF MOTION DECREASED 130
693 HIP FRACTURE 129
694 SKIN HAEMORRHAGE 129
695 ENCEPHALITIS CYTOMEGALOVIRUS 128
696 PETECHIAE 128
697 DRUG EFFECT INCOMPLETE 127
698 MALNUTRITION 127
699 PLASMA CELL MYELOMA 127
700 SKIN MASS 127
701 THERAPEUTIC RESPONSE SHORTENED 127
702 CRYING 126
703 GASTROINTESTINAL INFECTION 126
704 PRODUCT AVAILABILITY ISSUE 126
705 EYE HAEMORRHAGE 125
706 HAEMORRHOIDS 125
707 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 125
708 SCAR 125
709 CIRCULATORY COLLAPSE 124
710 TOOTH DISORDER 124
711 CHROMATURIA 123
712 ENCEPHALITIS VIRAL 123
713 PARVOVIRUS B19 INFECTION 123
714 RHINOVIRUS INFECTION 123
715 TRANSIENT ISCHAEMIC ATTACK 123
716 URINARY RETENTION 123
717 ESCHERICHIA SEPSIS 122
718 MASS 122
719 NO THERAPEUTIC RESPONSE 122
720 ABORTION SPONTANEOUS 121
721 AUTOIMMUNE HAEMOLYTIC ANAEMIA 121
722 BLOOD ALBUMIN DECREASED 121
723 GINGIVAL BLEEDING 121
724 OBESITY 121
725 SECRETION DISCHARGE 121
726 BLEPHARITIS 120
727 BLOOD SODIUM DECREASED 120
728 CARDIOMEGALY 120
729 MYOCLONUS 120
730 SCRATCH 120
731 AUTOIMMUNE DISORDER 119
732 ENTEROBACTER INFECTION 119
733 GASTROENTERITIS VIRAL 119
734 ORAL DISORDER 119
735 STREPTOCOCCAL INFECTION 119
736 CEREBRAL TOXOPLASMOSIS 118
737 HYPERTENSIVE CRISIS 118
738 INTENTIONAL DOSE OMISSION 118
739 MACULAR DEGENERATION 118
740 PRODUCT PACKAGING ISSUE 118
741 RESPIRATORY SYNCYTIAL VIRUS INFECTION 118
742 CYSTITIS VIRAL 117
743 DRUG DEPENDENCE 117
744 FACE OEDEMA 117
745 MYOSITIS 117
746 NODULE 117
747 RENAL TRANSPLANT 117
748 WOUND INFECTION 117
749 BRAIN ABSCESS 116
750 CHOLECYSTITIS 116
751 ENDOCARDITIS 116
752 GUILLAIN-BARRE SYNDROME 116
753 ILEUS 116
754 PEMPHIGUS 116
755 PHARYNGITIS 116
756 BLOOD POTASSIUM DECREASED 115
757 CARDIOVASCULAR DISORDER 115
758 CONCOMITANT DISEASE PROGRESSION 115
759 INTERVERTEBRAL DISC PROTRUSION 115
760 IRRITABLE BOWEL SYNDROME 115
761 PRODUCT COMPLAINT 115
762 SHOCK HAEMORRHAGIC 115
763 CHOLANGITIS 114
764 GROWTH RETARDATION 114
765 HAEMODYNAMIC INSTABILITY 114
766 HEAD INJURY 114
767 HERNIA 114
768 RIB FRACTURE 114
769 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 113
770 DYSSTASIA 113
771 ESCHERICHIA URINARY TRACT INFECTION 113
772 HYPOPHAGIA 113
773 NECROSIS 113
774 PRODUCT DISPENSING ERROR 112
775 EYELID MARGIN CRUSTING 111
776 HEPATOCELLULAR INJURY 111
777 PSYCHOTIC DISORDER 111
778 ELECTROLYTE IMBALANCE 110
779 FLUID OVERLOAD 110
780 HAEMATEMESIS 110
781 HYPERURICAEMIA 110
782 KIDNEY INFECTION 110
783 MUSCULOSKELETAL DISCOMFORT 110
784 RETINAL DETACHMENT 110
785 SEASONAL ALLERGY 110
786 ATELECTASIS 109
787 KAPOSI'S SARCOMA 109
788 POOR QUALITY PRODUCT ADMINISTERED 109
789 SOFT TISSUE DISORDER 109
790 TACHYPNOEA 109
791 ACUTE HEPATIC FAILURE 108
792 BLOOD URIC ACID INCREASED 108
793 CUSHING^S SYNDROME 108
794 FEAR OF INJECTION 108
795 HEPATIC CYTOLYSIS 108
796 ADRENAL INSUFFICIENCY 107
797 CENTRAL NERVOUS SYSTEM LESION 107
798 DEVICE MALFUNCTION 107
799 HYPERTRANSAMINASAEMIA 107
800 POLYNEUROPATHY 107
801 RED BLOOD CELL SEDIMENTATION RATE 107
802 BLOOD PRESSURE ABNORMAL 106
803 CARPAL TUNNEL SYNDROME 106
804 DIARRHOEA HAEMORRHAGIC 106
805 LIQUID PRODUCT PHYSICAL ISSUE 106
806 PRE-EXISTING CONDITION IMPROVED 106
807 AUTOIMMUNE HEPATITIS 105
808 GALLBLADDER DISORDER 105
809 SKIN HYPERPIGMENTATION 105
810 SMOOTH MUSCLE CELL NEOPLASM 105
811 SPINAL FRACTURE 105
812 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 104
813 PIGMENTATION DISORDER 104
814 PULMONARY TUBERCULOSIS 104
815 DYSKINESIA 103
816 HAEMATOTOXICITY 103
817 LARYNGITIS 103
818 MULTIPLE ALLERGIES 103
819 PANIC ATTACK 103
820 PAPULE 103
821 STENOTROPHOMONAS INFECTION 103
822 EYELIDS PRURITUS 102
823 GLOMERULONEPHRITIS 102
824 ACTINIC KERATOSIS 101
825 ANAPHYLACTIC SHOCK 101
826 EATING DISORDER 101
827 EOSINOPHILIA 101
828 FOETAL GROWTH RESTRICTION 101
829 HALLUCINATION, VISUAL 101
830 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 101
831 OESOPHAGITIS 101
832 RENAL TUBULAR ATROPHY 101
833 STATUS EPILEPTICUS 101
834 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 101
835 CAESAREAN SECTION 100
836 DYSLIPIDAEMIA 100
837 HYPERTRICHOSIS 100
838 HYPOCALCAEMIA 100
839 ORGANISING PNEUMONIA 100
840 SENSORY DISTURBANCE 100
841 SUBARACHNOID HAEMORRHAGE 100
842 SYSTEMIC MYCOSIS 100
843 TASTE DISORDER 100
844 BREATH SOUNDS ABNORMAL 99
845 DERMATITIS EXFOLIATIVE GENERALISED 99
846 DUODENAL ULCER PERFORATION 99
847 GRAFT DYSFUNCTION 99
848 PALLOR 99
849 SINUS CONGESTION 99
850 B-CELL LYMPHOMA 98
851 DEMENTIA 98
852 FEELING COLD 98
853 HEPATIC FIBROSIS 98
854 KNEE ARTHROPLASTY 98
855 DISSEMINATED ASPERGILLOSIS 97
856 FOOT FRACTURE 97
857 FRACTURE 97
858 JOINT EFFUSION 97
859 LYMPHOID TISSUE HYPOPLASIA 97
860 MITRAL VALVE INCOMPETENCE 97
861 PNEUMOMEDIASTINUM 97
862 TOXIC ENCEPHALOPATHY 97
863 BLOOD IRON ABNORMAL 96
864 CACHEXIA 96
865 FEMUR FRACTURE 96
866 FULL BLOOD COUNT DECREASED 96
867 PURPURA 96
868 RASH GENERALISED 96
869 ROTATOR CUFF SYNDROME 96
870 SERUM SICKNESS 96
871 THYMUS HYPOPLASIA 96
872 AGEUSIA 95
873 EAR DISCOMFORT 95
874 EJECTION FRACTION DECREASED 95
875 ENGRAFTMENT SYNDROME 95
876 HEPATIC ENCEPHALOPATHY 95
877 HIRSUTISM 95
878 LUNG TRANSPLANT REJECTION 95
879 MUSCLE TWITCHING 95
880 PNEUMONIA KLEBSIELLA 95
881 SCAB 95
882 ANKLE FRACTURE 94
883 APLASIA 94
884 ATAXIA 94
885 CATARACT OPERATION 94
886 MYOCARDITIS 94
887 OESOPHAGEAL CANDIDIASIS 94
888 TOOTHACHE 94
889 NEUROLOGICAL SYMPTOM 93
890 ACUTE PULMONARY OEDEMA 92
891 CARDIOGENIC SHOCK 92
892 CARDIOMYOPATHY 92
893 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 92
894 FAECES DISCOLOURED 92
895 GENERALISED TONIC-CLONIC SEIZURE 92
896 KERATITIS 92
897 RENAL TUBULAR INJURY 92
898 THROAT TIGHTNESS 92
899 VITAMIN D DEFICIENCY 92
900 EYE MOVEMENT DISORDER 91
901 FACIAL PAIN 91
902 HEPATITIS CHOLESTATIC 91
903 HYPOMAGNESAEMIA 91
904 RESTLESSNESS 91
905 SKIN PAPILLOMA 91
906 BLOOD CREATINE INCREASED 90
907 BLOOD MAGNESIUM DECREASED 90
908 COLON CANCER 90
909 DISABILITY 90
910 ENTEROCOLITIS 90
911 HEPATOSPLENOMEGALY 90
912 HIP ARTHROPLASTY 90
913 INTERNATIONAL NORMALISED RATIO INCREASED 90
914 MALABSORPTION 90
915 ABDOMINAL PAIN LOWER 89
916 DERMATITIS CONTACT 89
917 DRUG ADMINISTRATION ERROR 89
918 RASH PUSTULAR 89
919 ABASIA 88
920 APHTHOUS ULCER 88
921 BLOOD PRESSURE DIASTOLIC INCREASED 88
922 EYELID DISORDER 88
923 HEPATIC ENZYME ABNORMAL 88
924 NEOPLASM PROGRESSION 88
925 CAPILLARY LEAK SYNDROME 87
926 CORNEAL ABRASION 87
927 METASTASES TO LUNG 87
928 PAPILLOEDEMA 87
929 PERIORBITAL SWELLING 87
930 PLATELET COUNT ABNORMAL 87
931 PRODUCT ADMINISTRATION INTERRUPTED 87
932 RENAL TUBULAR DISORDER 87
933 TOXOPLASMOSIS 87
934 BLOOD PRESSURE DIASTOLIC DECREASED 86
935 DECREASED IMMUNE RESPONSIVENESS 86
936 HAIR GROWTH ABNORMAL 86
937 LIVER TRANSPLANT 86
938 MULTIPLE SCLEROSIS 86
939 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 86
940 STEROID DEPENDENCE 86
941 BONE MARROW TRANSPLANT 85
942 CYTOKINE RELEASE SYNDROME 85
943 JOINT DISLOCATION 85
944 RENAL CELL CARCINOMA 85
945 RENAL CYST 85
946 SKIN REACTION 85
947 AZOTAEMIA 84
948 BLOOD GLUCOSE DECREASED 84
949 BONE EROSION 84
950 CYTOMEGALOVIRUS ANTIGEN POSITIVE 84
951 GLUCOSE TOLERANCE IMPAIRED 84
952 LUPUS NEPHRITIS 84
953 RALES 84
954 RETINAL HAEMORRHAGE 84
955 SECONDARY IMMUNODEFICIENCY 84
956 ABNORMAL BEHAVIOUR 83
957 ACIDOSIS 83
958 BLOOD PRESSURE SYSTOLIC ABNORMAL 83
959 ERYTHRODERMIC PSORIASIS 83
960 FREQUENT BOWEL MOVEMENTS 83
961 HAEMORRHAGIC DIATHESIS 83
962 HYPERSOMNIA 83
963 LARGE INTESTINE PERFORATION 83
964 MYCOBACTERIUM CHELONAE INFECTION 83
965 PRURITUS GENERALISED 83
966 BLINDNESS UNILATERAL 82
967 CARDIAC FAILURE ACUTE 82
968 GRAFT LOSS 82
969 HEART RATE IRREGULAR 82
970 INFECTION REACTIVATION 82
971 MYCOBACTERIAL INFECTION 82
972 RESPIRATORY TRACT CONGESTION 82
973 BONE DISORDER 81
974 CRYPTOCOCCOSIS 81
975 NEOPLASM SKIN 81
976 OPPORTUNISTIC INFECTION 81
977 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 81
978 PROTEIN URINE PRESENT 81
979 TOOTH INFECTION 81
980 UPPER-AIRWAY COUGH SYNDROME 81
981 HYDROCEPHALUS 80
982 INTESTINAL PERFORATION 80
983 ORAL DISCOMFORT 80
984 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 80
985 TRANSFUSION 80
986 ARTHROPOD BITE 79
987 BURSITIS 79
988 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 79
989 GLYCOSYLATED HAEMOGLOBIN INCREASED 79
990 HORDEOLUM 79
991 HYPERTRIGLYCERIDAEMIA 79
992 LYMPHADENITIS 79
993 NEPHRECTOMY 79
994 ORAL ADMINISTRATION COMPLICATION 79
995 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 79
996 SKIN ATROPHY 79
997 TENDON RUPTURE 79
998 TONGUE ULCERATION 79
999 ANGIOPATHY 78